Vicor’s main risk is conversion, not relevance. It has a real product edge in dense power, but shareholder returns depend on turning
backlog and licensing into sustained shipments from a concentrated manufacturing base before larger rivals close the gap. If customer breadth stays narrow,
fab relief slips, or valuation normalizes faster than revenue scales, the business can improve while the stock still underwhelms.